Treatment of non-alcoholic fatty liver disease with focus on emerging drugs

Author： Marchesini Giulio   Moscatiello Simona   Agostini Federica   Villanova Nicola   Festi Davide  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.16, Iss.1, 2011-03, pp. : 121-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for non-alcoholic fatty liver disease

By Federico Alessandro   Niosi Marco   Vecchio Blanco Camillo Del   Loguercio Carmela  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 145-158

Informa Healthcare

Access to resources Recommend Favorite

Current best treatment for non-alcoholic fatty liver disease

By Angulo Paul  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 611-623

Informa Healthcare

Access to resources Recommend Favorite

Current Treatment Strategies for Non-Alcoholic Fatty Liver Disease (NAFLD)

By  

Current Drug Discovery Technologies, Vol. 4, Iss. 2, 2007-08 ,pp. : 133-140

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the treatment of non-alcoholic fatty liver disease

By Mendes Flavia D   Lindor Keith D  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 29-35

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease

By  

Current Drug Targets, Vol. 16, Iss. 12, 2015-10 ,pp. : 1324-1331

Bentham Science Publishers

Access to resources Recommend Favorite